Literature DB >> 26003053

Perceived ambiguity as a barrier to intentions to learn genome sequencing results.

Jennifer M Taber1, William M P Klein2, Rebecca A Ferrer2, Paul K J Han3, Katie L Lewis4, Leslie G Biesecker4, Barbara B Biesecker4.   

Abstract

Many variants that could be returned from genome sequencing may be perceived as ambiguous-lacking reliability, credibility, or adequacy. Little is known about how perceived ambiguity influences thoughts about sequencing results. Participants (n = 494) in an NIH genome sequencing study completed a baseline survey before sequencing results were available. We examined how perceived ambiguity regarding sequencing results and individual differences in medical ambiguity aversion and tolerance for uncertainty were associated with cognitions and intentions concerning sequencing results. Perceiving sequencing results as more ambiguous was associated with less favorable cognitions about results and lower intentions to learn and share results. Among participants low in tolerance for uncertainty or optimism, greater perceived ambiguity was associated with lower intentions to learn results for non-medically actionable diseases; medical ambiguity aversion did not moderate any associations. Results are consistent with the phenomenon of "ambiguity aversion" and may influence whether people learn and communicate genomic information.

Entities:  

Keywords:  Ambiguity aversion; Genetic/genome testing; Optimism; Perceived ambiguity; Response efficacy; Tolerance for uncertainty

Mesh:

Year:  2015        PMID: 26003053      PMCID: PMC4568142          DOI: 10.1007/s10865-015-9642-5

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  35 in total

1.  Varieties of uncertainty in health care: a conceptual taxonomy.

Authors:  Paul K J Han; William M P Klein; Neeraj K Arora
Journal:  Med Decis Making       Date:  2011 Nov-Dec       Impact factor: 2.583

2.  The costs of optimism and the benefits of pessimism.

Authors:  Kate Sweeny; James A Shepperd
Journal:  Emotion       Date:  2010-10

3.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

Review 4.  Psychosocial aspects of genetic testing.

Authors:  Linda D Cameron; Cecile Muller
Journal:  Curr Opin Psychiatry       Date:  2009-03       Impact factor: 4.741

5.  Participation in genetic testing research varies by social group.

Authors:  Sharon Hensley Alford; Colleen M McBride; Robert J Reid; Eric B Larson; Andreas D Baxevanis; Lawrence C Brody
Journal:  Public Health Genomics       Date:  2010-03-18       Impact factor: 2.000

6.  Motivators for participation in a whole-genome sequencing study: implications for translational genomics research.

Authors:  Flavia M Facio; Stephanie Brooks; Johanna Loewenstein; Susannah Green; Leslie G Biesecker; Barbara B Biesecker
Journal:  Eur J Hum Genet       Date:  2011-07-06       Impact factor: 4.246

7.  The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine.

Authors:  Leslie G Biesecker; James C Mullikin; Flavia M Facio; Clesson Turner; Praveen F Cherukuri; Robert W Blakesley; Gerard G Bouffard; Peter S Chines; Pedro Cruz; Nancy F Hansen; Jamie K Teer; Baishali Maskeri; Alice C Young; Teri A Manolio; Alexander F Wilson; Toren Finkel; Paul Hwang; Andrew Arai; Alan T Remaley; Vandana Sachdev; Robert Shamburek; Richard O Cannon; Eric D Green
Journal:  Genome Res       Date:  2009-07-14       Impact factor: 9.043

8.  Aversion to ambiguity regarding medical tests and treatments: measurement, prevalence, and relationship to sociodemographic factors.

Authors:  Paul K J Han; Bryce B Reeve; Richard P Moser; William M P Klein
Journal:  J Health Commun       Date:  2009-09

9.  Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk.

Authors:  Kurt D Christensen; J Scott Roberts; Wendy R Uhlmann; Robert C Green
Journal:  Genet Med       Date:  2011-05       Impact factor: 8.822

10.  Evaluating the utility of personal genomic information.

Authors:  Morris W Foster; John J Mulvihill; Richard R Sharp
Journal:  Genet Med       Date:  2009-08       Impact factor: 8.822

View more
  25 in total

1.  Current directions in behavioral medicine research on genetic testing for disease susceptibility: introduction to the special section.

Authors:  Kerry A Sherman; Linda D Cameron
Journal:  J Behav Med       Date:  2015-10

2.  Dispositional optimism and perceived risk interact to predict intentions to learn genome sequencing results.

Authors:  Jennifer M Taber; William M P Klein; Rebecca A Ferrer; Katie L Lewis; Leslie G Biesecker; Barbara B Biesecker
Journal:  Health Psychol       Date:  2014-10-13       Impact factor: 4.267

3.  Information Avoidance Tendencies, Threat Management Resources, and Interest in Genetic Sequencing Feedback.

Authors:  Jennifer M Taber; William M P Klein; Rebecca A Ferrer; Katie L Lewis; Peter R Harris; James A Shepperd; Leslie G Biesecker
Journal:  Ann Behav Med       Date:  2015-08

4.  Exploring the Issues Surrounding Clinical Exome Sequencing in the Prenatal Setting.

Authors:  Swetha Narayanan; Bruce Blumberg; Marla L Clayman; Vivian Pan; Catherine Wicklund
Journal:  J Genet Couns       Date:  2018-03-10       Impact factor: 2.537

5.  Optimism and Spontaneous Self-affirmation are Associated with Lower Likelihood of Cognitive Impairment and Greater Positive Affect among Cancer Survivors.

Authors:  Jennifer M Taber; William M P Klein; Rebecca A Ferrer; Erin E Kent; Peter R Harris
Journal:  Ann Behav Med       Date:  2016-04

6.  How Patients View Lung Cancer Screening. The Role of Uncertainty in Medical Decision Making.

Authors:  Marilyn M Schapira; Charu Aggarwal; Scott Akers; Jaya Aysola; Diana Imbert; Corey Langer; Charlie B Simone; Emily Strittmatter; Anil Vachani; Liana Fraenkel
Journal:  Ann Am Thorac Soc       Date:  2016-11

7.  "Something Extra on Chromosome 5": Parents' Understanding of Positive Prenatal Chromosomal Microarray Analysis (CMA) Results.

Authors:  Sarah A Walser; Allison Werner-Lin; Amita Russell; Ronald J Wapner; Barbara A Bernhardt
Journal:  J Genet Couns       Date:  2016-03-04       Impact factor: 2.537

8.  Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors.

Authors:  Kimberly A Kaphingst; Jennifer Ivanovich; Sarah Lyons; Barbara Biesecker; Rebecca Dresser; Ashley Elrick; Cindy Matsen; Melody Goodman
Journal:  Transl Behav Med       Date:  2018-01-29       Impact factor: 3.046

9.  Disclosure of cardiac variants of uncertain significance results in an exome cohort.

Authors:  T A Lawal; K L Lewis; J J Johnston; A R Heidlebaugh; D Ng; F G Gaston-Johansson; W M P Klein; B B Biesecker; L G Biesecker
Journal:  Clin Genet       Date:  2018-03-02       Impact factor: 4.438

10.  Perceptions of uncertainties about carrier results identified by exome sequencing in a randomized controlled trial.

Authors:  Kendall L Umstead; Paul K J Han; Katie L Lewis; Ilana M Miller; Charlotte L Hepler; Lydia J Thompson; Tyra G Wolfsberg; Anh-Dao Nguyen; Mark T Fredriksen; Gretchen Gibney; Erin Turbitt; Leslie G Biesecker; Barbara B Biesecker
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.